The emergence of cellular and molecular medicine provides academic health centers with unparalleled opportunities to re-engineer health research and patient care through innovation. Implementing innovation typically requires entrepreneurship, and unique component skills that include management, team building, and risk acceptance.
UTMB, in partnership with other universities and subject matter experts, aims to train physicians, faculty, fellows, pre-doctoral students, medical students, postdoctoral scientists and staff in the skills and knowledge needed to enhance entrepreneurial thinking. These advanced courses are formally offered through UTMB’s Human Pathophysiology and Translational Medicine (HPTM) Training doctoral program, jointly administered through UTMB's Institute for Translational Science and the UTMB Graduate School of Biomedical Sciences. UTMB graduate studies may enroll in these courses for credit; other graduate students may enroll for inter-institutional credit if their campus participates in the inter-institutional credit program.
BUSINESS INNOVATION for SUCCESSFUL ENTREPRENEURSHIP (HPTM 6307)
Jan 29 – May 6, 2016
student feedback / syllabus / registration form / reference materials / detailed syllabus / advisors
Offered largely online and taught by UT McCombs School of Business and subject matter experts.
Course director: Stan Watowich, PhD (contact firstname.lastname@example.org for additional information)
- 15 week course: Jan 29 – May 6, 2016 (see syllabus for exact dates & times)
- registration due Jan 4, 2016
- self-paced e-learning requires 3+ hr/wk
- online interactive sessions: Fri 1-2 PM
- space limited
- non-refundable fee payable to McCombs School of Business
- students (for students not enrolled for credit) $100
- researchers & staff $200
- faculty $500
- others $675
This course provides a detailed understanding of the steps to commercialize biomedical technologies and organize a successful startup business. For their capstone project, this course requires participants work through the process of forming a startup company to commercialize a biomedical product based on a new technology. Participants are expected to either have a new technology that they would like to commercialize or to work with their Technology Transfer Office to identify potential technologies. At the end of the course, each participant will deliver a business “pitch” to an Investor Panel and produce a Business Plan Executive Summary.
- Open to Texas faculty, students, fellows, staff, and affiliates.
- Taught by MBA faculty from UT-Austin McCombs School of Business and topic experts.
- Certificate from McCombs School of Business awarded upon successful completion.
- Graduate students can enroll for credit from UTMB’s Human Pathophysiology and Translational Medicine Graduate Program (course #HPTM 6307) by inter-campus registration.
- Class instruction and interactions occur largely online, thus removing distance barriers to participation.
- Participants will come to understand the life-cycle of a startup company, including steps to develop and launch successful startups.
- Participants learn to effectively communicate their venture by delivering an investor "pitch" to a panel of accomplished investors and entrepreneurs and preparing a business plan executive summary.
- Participants develop an understanding of technology assessment, persuasion and marketing strategies, financing options, product development management, IP, commercialization strategies, business plans, and creative management approaches.
- New tools, including leveraged social networks to analyze market opportunities, will be practiced to evaluate how to best position emerging technologies.
- Practical steps and “do-it-yourself” issues necessary to set up, structure (e.g., business plans, operating agreements), and exit startups will be presented.